Abstract Enterovirus A71 (EV-A71) and coxsackievirus A16 (CV-A16) are closely related enteroviruses that cause hand, foot and mouth disease (HFMD) in children. Serious neurological complications almost always occur in EV-A71 infection, but are rare in CV-A16 infection. Based on the hypothesis that this may be because EV-A71 infects neuronal cells more easily than CV-A16, we compared virus infection, replication and spread of EV-A71 and CV-A16 in SK-N-SH cells. We found that CV-A16 invariably showed significantly lower replication and caused less necrotic cell death in SK-N-SH cells, compared with EV-A71. This was not due to a lower proportion of CV-A16-infected cells, since both viruses showed similar proportions of infected cells at all time points analyzed. Furthermore, reduced replication of CV-A16 in SK-N-SH cells does not appear to be due to limited viral receptor availability, which might limit viral entry, because experiments with viral RNA-transfected cells showed the same results as for live virus infections. On the other hand, no differences were observed between EV-A71 and CV-A16 in RD cells and results were generally similar in RD cells for both viruses. Taken together, our findings suggest that the poor growth of CV-A16 and EV-A71in SK-N-SH cells, compared with RD cells, may be due to cell type-specific restrictions on viral replication and spread. Furthermore, the lower viral replication and necrotic cell death in CV-A16-infected SK-N-SH cells, compared with EV-A71-infected SK-N-SH cells, is consistent with the lower prevalence of neurotropism observed in CV-A16-associated HFMD outbreaks. Nonetheless, in vivo data and more extensive comparisons of different viral strains are essential to confirm our findings.
Introduction
Enterovirus 71 (EV-A71) and coxsackievirus A16 (CV-A16) are human enteroviruses belonging to the species Enterovirus A, genus Enterovirus, within the Picornaviridae family. Both viruses are *30 nm, each containing a single-stranded, positive-sense RNA genome of approximately 7.5 kbp and they share about 80% of sequence similarity [65] . Furthermore, they use the same Scavenger receptor class B, member 2 (SCARB2) as a receptor for cell entry and possibly other attachment receptors, such as P-selectin glycoprotein ligand-1 (PSGL-1) and heparin sulphate [49, [60] [61] [62] . EV-A71 and CV-A16 are known etiological agents for sporadic and epidemic hand, foot and mouth disease (HFMD), a common infectious disease frequently seen in young children aged 5 and below [44, 53, 54] . In recent years, large outbreaks of HFMD have been mainly reported in the Asia-Pacific region [1, 18, 19, 21, [32] [33] [34] . HFMD is characterized by lesions on the skin of the hand, foot, buttock and oral mucosa [25] .
EV-A71-associated HFMD is occasionally complicated by central nervous system (CNS) disease such as aseptic meningitis, acute flaccid paralysis and acute encephalomyelitis [6, 16, 25, 28, 33, 40] . In fatal cases, typical features of viral encephalitis, including perivascular and parenchymal infiltration by inflammatory cells, edema, neurophagia and neuron necrosis are mainly found in the brainstem and spinal cord [39, 63] . Viral antigens and RNA are only detected in neurons confirming that EV-A71 is neurotropic [30, 47, 55] . Although, EV-A71 has been studied extensively in vivo and in vitro [10, 13, 17] , its replication kinetics and spread in human neuronal cells have not been extensively investigated. On the other hand, CV-A16 is far less frequently associated with CNS manifestations despite several reports of CV-A16-associated HFMD [14, 52, 56] and CV-A16 viral antigens/RNA have never been detected in human CNS tissues. Therefore, it is still unclear whether CV-A16 could productively infect human neurons as CV-A16 infection in human neuronal cells has not been widely studied [31] .
In this study, we investigated the growth characteristics of EV-A71 strains, isolated from fatal encephalomyelitis and HFMD patients, and of CV-A16 strains, isolated from HFMD patients, in human neuroblastoma (SK-N-SH) and rhabdomyosarcoma (RD) cell lines. Herein we report differences between EV-A71 and CV-A16 infection in SK-N-SH cells that may help to further understand the neurotropism of these two viruses.
Material and methods

Viruses and cell lines
Three EV-A71 strains and three CV-A16 strains (Table 1) were studied. The EV-A71 13903 and 18431 strains and the CV-A16 South strain have been described in previous publications [38, 42, 50] . The other strains in Table 1 have not been published before. The viruses were grown and titrated in Vero cells (ATCC-CCL-81) as described previously [38] . Vero cells were propagated in Dulbecco's modified Eagle's medium (DMEM) (SIGMA, USA) supplemented with 5% fetal bovine serum (FBS). Human neuroblastoma (SK-N-SH) cells (ATCC-HTB-11) and human rhabdomyosarcoma (RD) cells (ATCC-CCL-136) were grown in DMEM supplemented with 10% FBS. Since RD cells were highly susceptible to EV-A71 and CV-A16 infections [29, 46, 59, 67] , this cell line was used as a positive control for viral infection throughout this study unless otherwise stated.
Viral titration
Supernatants were collected at 24, 48, 72 and 96 hours post-infection (hpi), centrifuged to remove cellular debris and stored at -80°C for subsequent extracellular viral titration. After removal of supernatants, the cells attached to the bottom of the well were frozen at -80°C, followed by three freeze and thaw cycles, before intracellular virus titration. The virus titer was determined by a standard microtitration assay in Vero cells as previously described [22] . Briefly, up to eight-fold serial dilutions of the virus inoculum were prepared in complete medium. Fifty ll/well of serially diluted inoculum were incubated with Vero cells at 37°C for 2 h, followed by addition of 100 ll/well of fresh medium and incubation at 37°C for 7 days. The viral titer obtained was expressed as CCID 50 /ml.
Growth kinetics of viral strains in infected cells
Trypsinized cells were re-suspended in 2.0 ml microcentrifuge tubes and infected with EV-A71 or CV-A16, at a multiplicity of infection (MOI) of 10, for 2 h in a shaking incubator at 37°C, before centrifugation at 400g. Pellets of infected cells were washed twice with phosphate-buffered saline (PBS) before plating on 24-well plates. Cells and/or supernatants were harvested at 24, 48 and 72 hpi for viral titration in triplicates. cells/ml), seeded and infected in a Lab-Tek 8-well chamber slide system (Nunc, Denmark), were stained according to the manufacturer's protocol [36, 43] . Cells were incubated with the apoptosis and necrosis reagents in staining buffer (Enzo, USA) for 30 min. After fixation with Fluorofix buffer for 30 min at RT, the viral antigens were stained according to the manufacturer's instructions, for flow cytometry analysis. The cells were mounted using fluorescence mounting medium (Dako, Denmark) and analyzed using a Leica automated fluorescence microscope DM6000. Cells treated with straurosporine and NaCl [23] were used as positive controls for apoptosis and necrosis, respectively.
Virus RNA transfection
EV-A71 13903 and CV-A16 N132 RNAs were extracted from the supernatant of infected Vero cells. Briefly, the supernatants were centrifuged to remove cellular debris. Viral RNA was extracted from 200 ll of supernatant using High Pure Viral RNA extraction kit (Roche, Switzerland), as described in the manufacturer's protocol, and frozen at -80°C before use. Viral 
Statistical analysis
Data was reported as mean ± standard deviation from at least three independent experiments. The unpaired student t-test from the Statistical Package for the Social Sciences (SPSS) software was used to calculate p values. P values of \0.05 were considered significant.
Results
CV-A16 and EV-A71 infection in SK-N-SH cells
In CV-A16-infected SK-N-SH cells, viral titers showed a slight increase from 24 to 72 hpi. However, no significant differences were observed in viral titers between all three CV-A16 strains at any of the time points analyzed (Fig. 1a) . Similarly, titers for all three EV-A71 strains increased from 24 to 72 hpi (Fig. 1b) , with no significant differences between strains. However, all CV-A16 viral strains showed significantly lower titers than the EV-A71 strains at all time points (p \ 0.05). These results suggest that CV-A16 infects SK-N-SH cells less readily than EV-A71. We chose the EV-A71 13903 strain and the CV-A16 N132 strain, which showed the highest replication in SK-N-SH cells, for further experiments.
To exclude the possibility that the lower CV-A16 titers observed were due to lower viral entry into SK-N-SH cells, flow cytometry analysis was performed (Fig. 2a) . We found that the proportion of SK-N-SH cells infected by both viruses were similar throughout, increasing from 60% to 72% (p [ 0.05). The proportions of RD cells infected by both viruses were also similar, increasing from 60% to 95% throughout (p [ 0.05; Fig. 2a) . Hence, these results suggest that in SK-N-SH cells, CV-A16 replicated less efficiently than EV-A71. Positive controls for Alexa-fluor 488 and 7-AAD showed 70% and 90% of stained cells, respectively, and non-infected control cells were 98% unstained for both SK-N-SH and RD cell lines at 48 hpi (Fig. 2b) .
Necrotic cell death in infected SK-N-SH cells
CV-A16-and EV-A71-infected SK-N-SH cells were positive only for 7-ADD (necrosis) but negative for Annexin V (apoptosis), using GFP-Certified Apoptosis/ Necrosis staining kit (Fig. 3) . Flow cytometry analysis showed that CV-A16 induced SK-N-SH cell necrosis in 1%-18% of cells, and EV-A71 induced necrosis in 5%-41% (Fig. 2a) . The proportions of necrotic cells during CV-A16 infection were consistently and significantly lower than those observed with EV-A71 at 48, 72 and (Fig. 2a) . These observations suggest that CV-A16 infection caused less necrotic cell death than EV-A71. In RD cells, EV-A71 induced necrosis in 1%-80% of cells (Fig. 2a) and this was significantly higher than in SK-N-SH cells at 48, 72 and 96 hpi. CV-A16-induced necrosis in RD cells ranged from 2% to 79% (Fig. 2a) and was significantly higher than in SK-N-SH cells at 48, 72 and 96 hpi. Thus, EV-A71 not only appears to replicate faster, but may also cause more necrosis in SK-N-SH cells at 48-96 hpi, compared with CV-A16 (Fig. 2a) .
Growth kinetics of CV-A16 and EV-A71 in infected SK-N-SH and RD cells
To confirm the flow cytometry results that showed no significant increase in intracellular viral antigens in SK-N-SH cells (Fig. 2a) , we determined the intracellular and extracellular viral titers of CV-A16 and EV-A71, in both SK-N-SH cells and RD cells. In SK-N-SH cells, intracellular viral titer of CV-A16 showed no significant increase, while extracellular viral titer was reduced throughout the infection (Fig. 4a) . However, in RD cells intracellular and extracellular viral titer of CV-A16 showed significant increase at 48 hpi (Fig. 4b) , consistent with the increasing proportion of RD infected cells (Fig. 2a) . In EV-A71-infected SK-N-SH cells, a gradual increase in intracellular and extracellular viral titers was observed throughout the infection (Fig. 4c ), but the increase was not significant. On the other hand, EV-71 infection of RD cells showed a significant increase in intracellular and extracellular viral titers at 72 hpi (Fig. 4d) , consistent with the increasing proportion of RD infected cells (Fig. 2a) . These results suggest that both viruses do not appear to spread efficiently in SK-N-SH cells compared with RD cells.
CV-A16 and EV-A71 RNA transfection in SK-N-SH and RD cells
Viral RNA was transfected into both cell lines to investigate if the restriction of viral replication in SK-N-SH cells occurred as a result of viral entry or replication failure. (Fig. 5a ) were significantly lower (p \ 0.05) than those detected with EV-A71 RNA (Fig. 5a ) at 24 and 48 h post-transfection. However, infectious viral titers recovered from viral RNA transfected-RD cells showed no statistically significant difference between CV-A16 and EV-A71, at either time-point (Fig. 5b) . Furthermore, flow cytometry analysis of CV-A16 and EV-A71 antigens showed that the proportions of successfully transfected SK-N-SH and RD cells were not statistically different (p [ 0.05) (Fig. 6a) . Thus, following transfection, the lower titers observed with CV-A16, compared with EV-A71, do not appear to be due to differences in the proportion of transfected cells (Fig. 6a) . These findings correlate well with live virus infection experiments (Figs. 1 and 4 ) and are consistent with the notion that CV-A16 replicates less easily than EV-A71 in SK-N-SH cells. As a control, the transfection efficiency, determined using a GFP expression vector, showed no statistically significant difference in the percentage of GFP-expressing cells in SK-N-SH and RD cell lines at the 48 h posttransfection time-point (p = 0.3821; Fig. 6b ), suggesting that the transfection efficiency for both cell lines was similar and hence the viral titers for both viruses, in SK-N-SH and RD cells, were comparable. Non-infected controls showed 98% of unstained cells (Fig. 6b) .
Discussion
In this study we investigated viral replication kinetics following live virus infection and RNA transfection of CV-A16 and EV-A71 in SK-N-SH cells. Following infection of SK-N-SH cells, all CV-A16 viral strains appeared to show limited growth (Fig. 1a) . Moreover, intracellular and extracellular viral titers of CV-A16 and EV-A71 were significantly lower in SK-N-SH cells, compared with RD cells. This observation also correlated well with viral RNA transfection results, also showing lower CV-A16 replication (Fig. 5a ) than EV-A71 (Fig. 5b) . Each viral titer represents the mean ± standard deviation of a set of triplicates in SK-N-SH cells, compared with RD cells, throughout the infection. We believe that the lower CV-A16 replication observed in SK-N-SH cells is not due to fewer cells being infected, as the percentages of infected cells were consistently similar to EV-A71 (Fig. 2a) . Similarly, following transfection, the proportion of transfected cells was also comparable for both viruses at 24 and 48 h (Fig. 6a) . Thus, the overall data support the notion that CV-A16 may replicate in SK-N-SH cells less easily than EV-A71. Furthermore, these results also suggest that SK-N-SH cells may impede the growth and replication of both viruses, especially CV-A16. Nonetheless, it has to be emphasized 
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RD cell that our in vitro findings cannot be so readily extrapolated to natural infection and need to be confirmed by in vivo data.
To our knowledge, our study is the first to compare EV-A71 and CV-A16 viral replication and spread in neuronal cells. In a previous study using SH-SY5Y cells, another human neuroblastoma cell line, EV-A71 infection, with an MOI lower than 1, peaked at 24 h and gradually decreased [8, 58] . However, the authors failed to explain the halt in viral spread at 24 hpi. Although not exactly comparable, our study showed that EV-A71 replication was the highest at 72 h, suggesting that viral infection may persist longer at a higher MOI (MOI = 10) than with a lower viral load. Li and colleagues (2014) also found that CV-A16 was able to infect SK-N-SH cells with a similar increase in virus titer from 12 to 48 h, but data beyond 48 h was not available [27] . Unfortunately, no comparison was made with EV-A71 infection in that paper. Assuming that CV-A16 is potentially able to invade the CNS parenchyma in a similar way to EV-A71, and that different CV-A16 strains are fundamentally different from EV-A71 strains, lower viral replication may help explain the much lower incidence of CNS diseases in CV-A16-associated HFMD outbreaks [57] .
We believe that the reason for a lower susceptibility to CV-A16 infection for SK-N-SH cells is probably not related to variations in viral receptor availability, as CV-A16 and EV-A71 infected similar proportions of cells in SK-N-SH and RD cell lines at 24 hpi (Fig. 3) . However, the observed differences in viral replication in SK-N-SH cells may be due to genomic differences between EV-A71 and CV-A16. Despite a generally high nucleotide homology (e.g. 93% nucleotide homology in the 5'UTR), significant differences between these two viruses may still exist [66] . Interestingly, point mutations in the internal ribosomal entry site (IRES) of the 5 0 UTR and/or 3 0 UTR of poliovirus strains affected its viral replication in neuronal cells [2, 11, 15, 64] . Our preliminary sequencing data from the 5 0 UTR showed only 84% homology, with 118 bp mismatches between EV-A71 13903 and CV-A16 N132 (unpublished data). Further investigations are needed to determine if differences in 5 0 UTR and other genomic regions may account for the observed differences in CV-A16 and EV-A71 viral replication in neuronal cells.
Cell type-specific restrictions on viral replication, for both viruses, in SK-N-SH cells, compared with RD cells, may also be responsible for the lower replication efficiency. Previously, SK-N-SH cells have been shown to mount protective anti-viral responses, by expression of IFN-a/b, against attenuated Sabin poliovirus strain, but not against wild-type poliovirus, following infection [35] . Similar responses may be evoked after CV-A16 and EV-A71 infections: EV-A71 may be able to overcome antiviral immune responses or evade host cell restrictions on viral replication better that CV-A16, leading to higher viral titers. Further investigations are needed to identify host cell responses that could impact on viral replication of both viruses in SK-N-SH and RD cells, to explain the differences observed in our study.
Several studies have shown that EV-A71 can induce apoptosis in human neuroblastoma (SK-N-SH and SK-N-MC), RD and glioblastoma cell lines [5, 7, 26, 46, 48] . However, we found no evidence of apoptosis in CV-A16-and EV-A71-infected SK-N-SH cells, but necrosis was prominent (Fig. 4a) . The GFP-Certified Apoptosis/Necrosis staining kit uses Annexin V as a well-recognized and reliable marker for apoptosis, and this kit has been previously used in many other studies to detect apoptosis [3, 36, 37] . Hence, we believe our findings to be credible. The association of apoptosis with EV-A71 infection reported in other studies may be due to the use of different methodologies, such as TUNEL and DNA fragmentation analysis, methods which may not be specific for apoptosis [12, 24] . Further investigations are needed to confirm the relationship between apoptosis and EV-A71. On the other hand, in human EV-A71 encephalomyelitis autopsies no apoptosis has been reported [4, 39] . Since EV-A71 appeared to induce higher levels of necrosis in SK-N-SH cells compared with CV-A16 (Fig. 3) , it could potentially cause more neuronal damage/death than CV-A16. This may contribute to the much higher incidence of fatal encephalomyelitis in EV-A71 infection.
A limitation of our experiments is that we did not use a CV-A16 strain isolated from brains, but to the best of our knowledge, a CNS-derived CV-A16 strain has not been reported in the literature. However, a brain-isolated EV-A71 strain did not show significant difference in viral replication kinetics compared to non-CNS-or HFMD-EV-A71 strains. Furthermore, the overall rate of enterovirus isolation from the CSF/CNS tissues remained very low (\5%) or was simply unavailable [9, 45] , even for EV-A71. Since SK-N-SH cells are neoplastic cells and may not be, physiologically or functionally, similar to normal human neurons, our results should be verified using nonneoplastic cells, e.g. human neurospheres or human neuroprogenitor differentiated neurons (mature neurons), as an experimental infection model. It is important that our in vitro experiments with SK-N-SH cells will be confirmed using data from in vivo investigations.
Conclusion
In conclusion, our data suggest that CV-A16 replicates less readily and causes less necrotic cell death in neuronal cells than EV-A71. In addition, SK-N-SH cells, and possibly neuronal cells in general, may not support viral growth, mirroring the relatively low incidence of EV-A71 encephalomyelitis and the low viral isolation rate from brain or CSF in fatal cases. Our results are also consistent with the lower number of cases with CNS manifestations observed in CV-A16-associated HFMD outbreaks. Nonetheless, in vivo data are needed to confirm our findings.
